MRI-guided Bone Marrow Biopsies of Advanced CaP Patients
- This study involves a one-time, MRI-guided bone marrow biopsy. Prior to this
procedure, patients will need to have a bone scan performed within the last three
months and a PSA blood test drawn within one month of registration to the study.
- Patients are also required to participate in the DFCI research study "Collection of
Specimens and Clinical Data for Patients with Prostate Cancer or at High Risk for
Prostate Cancer".
Interventional
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
To compare the yield of detecting metastatic prostate cancer tissue using MRI-guided bone marrow needle biopsies to that of historical controls obtained through unguided biopsies.
Mary-Ellen Taplin, MD
Principal Investigator
Dana-Farber Cancer Institute
United States: Institutional Review Board
01-108
NCT00165386
July 2001
January 2006
Name | Location |
---|---|
Dana-Farber Cancer Institute | Boston, Massachusetts 02115 |